Literature DB >> 24746458

Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primates.

Weiqi Pan1, Ling Han2, Zhenyuan Dong3, Xuefeng Niu1, Zhengfeng Li3, Linlin Bao4, Chufang Li1, Qinfang Luo1, Zifeng Yang1, Xiaobo Li4, Jicheng Huang5, Liqiang Feng3, Chuan Qin4, Nanshan Zhong1, Ling Chen6.   

Abstract

We evaluated the immunogenicity of hemagglutinin (HA) in the context of inactivated H7N9/AH/1/13-PR8 whole-virion. At 4weeks after immunization with 15μg HA, mice produced hemagglutination inhibition (HI) titers of 1:192 and neutralizing antibodies of 1:317. Aluminum hydroxide (alum), or a booster immunization, or both increased HI to 1:768, 1:384, 1:896 and neutralizing antibodies to 1:1868, 1:2302, 1:10,000, respectively. Macaques generated HI of 1:190 or 1:360 and virus neutralizing titers of 1:280 or 1:658 at 3weeks after immunization with HA alone or with alum. Sera from immunized mice and macaques protected mice from infection of A/Anhui/1/2013 (H7N9), suggesting an H7N9 vaccine is immunologically feasible.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; H7N9; Hemagglutinin; Influenza; Neutralization

Mesh:

Substances:

Year:  2014        PMID: 24746458     DOI: 10.1016/j.antiviral.2014.04.003

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  9 in total

Review 1.  The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.

Authors:  A Sally Davis; Jeffery K Taubenberger; Mike Bray
Journal:  Antiviral Res       Date:  2015-03-05       Impact factor: 5.970

2.  L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.

Authors:  Yang Wang; Yunhua Lv; Xuefeng Niu; Ji Dong; Pei Feng; Qinming Li; Wei Xu; Jiashun Li; Chufang Li; Jiahui Li; Jia Luo; Zhixia Li; Yichu Liu; Yee-Joo Tan; Weiqi Pan; Ling Chen
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

Review 3.  Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.

Authors:  William J Liu; Haixia Xiao; Lianpan Dai; Di Liu; Jianjun Chen; Xiaopeng Qi; Yuhai Bi; Yi Shi; George F Gao; Yingxia Liu
Journal:  Front Med       Date:  2021-04-16       Impact factor: 4.592

4.  Meeting report: the 4th symposium on animal models of non-human primates in Kunming, Yunnan, China.

Authors:  Jia-Li Li; Yong-Tang Zheng; Xu-Dong Zhao; Xin-Tian Hu
Journal:  Zool Res       Date:  2016-11-18

5.  Development of in vitro and in vivo neutralization assays based on the pseudotyped H7N9 virus.

Authors:  Yabin Tian; Hui Zhao; Qiang Liu; Chuntao Zhang; Jianhui Nie; Weijing Huang; Changgui Li; Xuguang Li; Youchun Wang
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

6.  Phenotypic Characterization of Chinese Rhesus Macaque Plasmablasts for Cloning Antigen-Specific Monoclonal Antibodies.

Authors:  Fan Zhang; Longyu Wang; Xuefeng Niu; Jiashun Li; Jia Luo; Yupeng Feng; Yanjia Yang; Ping He; Wenxia Fan; Renshan Liang; Zhiqiang Zheng; Weiqi Pan; Chufang Li; Yee Joo Tan; Haijian Yu; Ling Chen; Pingchao Li
Journal:  Front Immunol       Date:  2019-10-11       Impact factor: 7.561

7.  Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design.

Authors:  Zenglei Hu; Xinan Jiao; Xiufan Liu
Journal:  Front Microbiol       Date:  2017-09-26       Impact factor: 5.640

8.  Patient-derived avian influenza A (H5N6) virus is highly pathogenic in mice but can be effectively treated by anti-influenza polyclonal antibodies.

Authors:  Weiqi Pan; Haojun Xie; Xiaobo Li; Wenda Guan; Peihai Chen; Beiwu Zhang; Mincong Zhang; Ji Dong; Qian Wang; Zhixia Li; Shufen Li; Zifeng Yang; Chufang Li; Nanshan Zhong; Jicheng Huang; Ling Chen
Journal:  Emerg Microbes Infect       Date:  2018-06-13       Impact factor: 7.163

9.  Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development.

Authors:  Ting-Hsuan Chen; Wen-Chun Liu; I-Chen Chen; Chia-Chyi Liu; Ming-Hsi Huang; Jia-Tsrong Jan; Suh-Chin Wu
Journal:  Vaccine       Date:  2019-08-02       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.